RJA
BFYT

Raymond James & Associates’s Benefytt Technologies, Inc. Class A Common Stock BFYT Stock Holding History

Raymond James & Associates’s Portfolio BFYT Stock Details BFYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-11,789
Closed -$264K – 3713
2020
Q1 		$264K Sell
11,789
-79,914
-87% -$1.9M ﹤0.01% 2855
2019
Q4 		$1.77M Sell
91,703
-52,877
-37% -$1.19M ﹤0.01% 1899
2019
Q3 		$3.6M Sell
144,580
-3,793
-3% -$79.7K 0.01% 1420
2019
Q2 		$3.85M Buy
148,373
+49,197
+50% +$1.24M 0.01% 1378
2019
Q1 		$2.66M Buy
99,176
+91,252
+1,152% +$3.23M ﹤0.01% 1577
2018
Q4 		$212K Sell
7,924
-45,159
-85% -$1.81M ﹤0.01% 3094
2018
Q3 		$3.27M Sell
53,083
-5,854
-10% -$267K 0.01% 1490
2018
Q2 		$1.91M Buy
58,937
+20,117
+52% +$613K ﹤0.01% 1774
2018
Q1 		$1.12M Buy
+38,820
New +$1.09M ﹤0.01% 2053
2016
Q4 		– Sell
-27,050
Closed -$142K – 3405
2016
Q3 		$142K Sell
27,050
-330
-1% -$1.56K ﹤0.01% 2942
2016
Q2 		$108K Sell
27,380
-19,450
-42% -$114K ﹤0.01% 2787
2016
Q1 		$286K Sell
46,830
-18,203
-28% -$109K ﹤0.01% 2360
2015
Q4 		$436K Buy
65,033
+17,603
+37% +$90.2K ﹤0.01% 2059
2015
Q3 		$237K Sell
47,430
-1,400
-3% -$6.65K ﹤0.01% 2205
2015
Q2 		$243K Buy
48,830
+9,950
+26% +$62.7K ﹤0.01% 2332
2015
Q1 		$304K Sell
38,880
-7,800
-17% -$58.9K ﹤0.01% 2212
2014
Q4 		$334K Sell
46,680
-61,750
-57% -$521K ﹤0.01% 2094
2014
Q3 		$1.17M Buy
108,430
+80,531
+289% +$1M 0.01% 1402
2014
Q2 		$344K Buy
+27,899
New +$287K ﹤0.01% 1997
2013
Q4 		– Sell
-31,150
Closed -$372K – 2052
2013
Q3 		$372K Buy
31,150
+9,300
+43% +$105K ﹤0.01% 1704
2013
Q2 		$230K Buy
+21,850
New +$272K ﹤0.01% 1807

Other funds holding BFYT

RL
Ruffer LLP London, United Kingdom $2.44B AUM 44.75% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
RCG
Rock Creek Group Washington, District of Columbia $988M AUM 8.89% 1-Year Est. Return
CRM
Capital Returns Management Rye, New York $38.7M AUM 15.35% 1-Year Est. Return

Raymond James & Associates's BFYT Position: Q2 2020 in Review

Raymond James & Associates sold out of Benefytt Technologies, Inc. Class A Common Stock (BFYT) in Q2 2020, closing a stake of 11,789 shares — an estimated $264K sold.

Raymond James & Associates first reported a position in BFYT in Q2 2013 and held it in 21 quarters. The position peaked at $3.85M in Q2 2019. 89 funds tracked by Wall St. Rank hold BFYT as of Q2 2020.

  • Raymond James & Associates reported no remaining Benefytt Technologies, Inc. Class A Common Stock position as of Q2 2020 after selling out during the quarter.
  • Raymond James & Associates sold 11,789 Benefytt Technologies, Inc. Class A Common Stock shares in Q2 2020, an estimated $264K.
  • Raymond James & Associates first reported a position in Benefytt Technologies, Inc. Class A Common Stock in Q2 2013 and held it in 21 quarters.
  • Raymond James & Associates's Benefytt Technologies, Inc. Class A Common Stock position peaked at $3.85M in Q2 2019.
  • 89 funds tracked by Wall St. Rank held Benefytt Technologies, Inc. Class A Common Stock as of Q2 2020.

Based on Raymond James & Associates's 13F filing for Q2 2020, filed 28 Jul 2020.